rs781745126-T confers a fivefold increased risk of vitiligo, but neither of the LAG3 variants associated with other autoimmune diseases or with cancer after multiple testing correction, although the power to detect associations of lower magnitude or in less common diseases is limited for such rare variants. Here, LAG3 is linked to cancer.